Smith & Nephew plc (SN.) Ordinary USD0.20
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Contact details
Important dates
General stock information
- EPIC:
- SN.
- ISIN:
- GB0009223206
- Market cap:
- £8.65 billion
- Shares in issue:
- 871.98 million
- Sector:
- Health Care Equipment & Services
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- FTSE 100,FTSE techMARK 100,FTSE 350,FTSE All Share,FTSE techMARK All Share
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.